CClinicalTrials.gg
CompletedNCT01926925Updated Aug 21, 2013

Endothelial Function in Hispanic Children/Adolescents at Risk for Type 2 Diabetes

An observational study in Obesity and Insulin Resistance, sponsored by Joslin Diabetes Center. Completed. Open to participants aged 10 Years to 18 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2013-08-21.

Sponsored by Joslin Diabetes Center · Observational

Study type
Observational
Time perspective
Cross-sectional
Enrollment
38
Ages
10 Years to 18 Years
Sex
All
01

Study summary

Type 2 diabetes is now more frequent in children/adolescents, especially in those from minority populations, including Hispanic Americans (HA). Diabetes and the pre-diabetes state markedly increase the risk of cardiovascular disease. Endothelial dysfunction is seen in the earliest stages of atherogenesis, which ultimately leads to cardiovascular disease. The main aim of this study is to evaluate the endothelial function in HA children/adolescents who are at risk for developing type 2 diabetes (obese children/adolescents from the Hispanic population).

The investigators' hypothesis is that endothelial dysfunction is present in this population and that it is associated with metabolic abnormalities linked to the insulin resistance syndrome. The investigators will study 2 groups of 15 individuals each, age 10-18 years. Group 1 will consist of obese (body mass index greater than 85th percentile for age and sex) Hispanic American children/adolescents and group 2 will consist of healthy, non-overweight (body mass index between the 25th and 50 th percentile for age and sex) Hispanic American children/adolescents.

The study will be carried out at the Joslin Diabetes Center. During the first day, participants will have a medical history and full physical examination, a standard OGTT and measurement of blood cell count, plasma glucose, insulin, lipids, HbA1c, BUN, creatinine, electrolytes, estradiol, testosterone, free fatty acids, CRP, endothelial markers, urinary microalbumin and hCG, if appropriate. An OGTT will be performed in order to rule out IGT or Diabetes. Estimations of insulin secretion and insulin sensitivity will be assessed using the homeostasis model assessment (HOMA). In the second day, the body composition and the brachial artery vasodilatory response to hyperemia will be assessed. Those found with diabetes will be tested for GAD-65 and IA2.

The investigators' hypothesis is that Hispanic American children/adolescents at risk for type 2 diabetes have impaired endothelial function and vascular reactivity that are associated with the degree of insulin resistance and its metabolic abnormalities.

Read the detailed description

Information as above

02

Conditions studied

  • Obesity
  • Insulin Resistance

Keywords

  • Type 2 diabetes, Endothelium, children/adolescents
03

In context

Diabetes Mellitus, Type 2

9,359 studies on the registry are indexed under Diabetes Mellitus, Type 2; 1,318 are open to participants now.

This study's enrollment of 38 is below the median of 300 across 1,588 observational studies indexed under Diabetes Mellitus, Type 2.

Browse Diabetes Mellitus, Type 2 studies →

Lead sponsor

Joslin Diabetes Center is the lead sponsor of 79 studies on the registry; 7 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
10 Years to 18 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Probability sample

Study population

Hispanic children/adolescents

Inclusion criteria

  • Group 1:

    1. Age between 10-18 years;
    2. Hispanic (we will consider a subject being Hispanic if both parents are reported as Hispanics when asked the following question: "What ethnic group do you consider that you belong to?");
    3. No history of type 2 diabetes in any first-degree relative;
    4. Body mass index between the 25th and 50th percentile for age and sex
    5. Not have participated in any exercise program for the 6 months prior to the beginning of the study.

Group 2:

  1. Age between 10-18 years;
  2. Hispanic (same criteria as above);
  3. Body mass index greater than the 85th percentile for age and sex;
  4. Not have participated in any exercise program for the 6 months prior to the beginning of the study.

Exclusion criteria

Exclusion Criteria:

  • The exclusion criteria include: diabetes, pregnancy, smoking, cardiovascular disease, uncontrolled hypertension, renal disease, proteinuria, cancer, infectious diseases, severe GI diseases, lung disease, electrolyte abnormalities, anemia, endocrine disorders, severe dyslipidemia, peripheral vascular disease, medications: beta-blockers, any diuretic, calcium channel blockers, ACE inhibitors, niacin, glucocorticoids, any antineoplastic agent, antibiotics, psychoactive agents, bronchodilators or insulin.
05

Study design

Time perspective
Cross-sectional
Enrollment
38 participants (actual)
Biospecimen retention
Samples without dna

Groups and cohorts

  • 1

    Overweight Hispanic children/adolescents

  • 2

    Lean Hispanic children/adolescents

06

What researchers measure

Primary outcomes

  1. Plasma levels of markers of endothelial activation and vascular inflammation

    Time frame: cross sectional study - one time evaluation

07

Study locations

No study locations are listed for this record.

08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 21, 2013, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT01926925
Lead sponsor
Joslin Diabetes Center
Responsible party
Enrique Caballero (Clinical Investigator/Director Latino Diabetes Initiative, Joslin Diabetes Center) — Principal investigator
First posted
Aug 21, 2013
Start date
May 2001
Primary completion
May 2010
Completion
Feb 2012
Last update
Aug 21, 2013

Study contacts

Enrique Caballero, MD
principal investigator · Joslin Diabetes Center

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2013. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion